These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2186854)

  • 1. A controlled trial of bestatin in hydatidiform mole.
    Ho PC; Wong LC; Lawton JW; Ma HK
    Cancer Immunol Immunother; 1990; 31(3):187-90. PubMed ID: 2186854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic effect of bestatin on the onset of invasive mole--clinical and fundamental studies.
    Asada E; Mano H; Yamada A; Ino K; Ishizuka T; Goto S; Tomoda Y
    Biotherapy; 1992; 5(2):145-52. PubMed ID: 1524955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
    Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
    Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
    Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological parameters in gestational trophoblastic neoplasia.
    Ho PC; Mak LW; Lawton JW; Ma HK
    J Reprod Immunol; 1980 Feb; 1(5-6):307-19. PubMed ID: 6251216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
    Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
    Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin: a new circulating marker of hydatidiform mole?
    Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
    BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M; Bagshawe KD
    Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.